Slate Path Capital LP - Q1 2009 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q1 2009
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N33Q2 202415.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW27Q2 202411.4%
NEW YORK TIMES CO26Q2 202410.9%
VANECK VECTORS ETF TR24Q2 202419.5%
PAN AMERN SILVER CORP24Q2 20247.6%
CUE BIOPHARMA INC20Q2 20241.3%
BARRICK GOLD CORPORATION17Q2 202415.7%
VANECK VECTORS ETF TR17Q2 20245.9%
SNAP INC15Q4 202319.7%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q1 2009 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyclerion Therapeutics, Inc.January 22, 2024357,88014.6%
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14

View Slate Path Capital LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings

CSVXLS